Medtech Acquisition Corp
NASDAQ:MTAC
Intrinsic Value
MedTech Acquisition Corp. is a blank check company, whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinat... [ Read More ]
There is not enough data to reliably calculate the intrinsic value of MTAC.
Fundamental Analysis
Balance Sheet Decomposition
Medtech Acquisition Corp
Current Assets | 300.9k |
Cash & Short-Term Investments | 136.8k |
Other Current Assets | 164.1k |
Non-Current Assets | 20.2m |
Other Non-Current Assets | 20.2m |
Current Liabilities | 4.7m |
Accounts Payable | 1.6m |
Other Current Liabilities | 3.1m |
Non-Current Liabilities | 9.5m |
Other Non-Current Liabilities | 9.5m |
Earnings Waterfall
Medtech Acquisition Corp
Revenue
|
0
USD
|
Operating Expenses
|
-2.9m
USD
|
Operating Income
|
-2.9m
USD
|
Other Expenses
|
5.2m
USD
|
Net Income
|
2.3m
USD
|
Free Cash Flow Analysis
Medtech Acquisition Corp
MTAC Profitability Score
Profitability Due Diligence
Medtech Acquisition Corp's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
Score
Medtech Acquisition Corp's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
MTAC Solvency Score
Solvency Due Diligence
Medtech Acquisition Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Score
Medtech Acquisition Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MTAC Price Targets Summary
Medtech Acquisition Corp
Shareholder Return
MTAC Price
Medtech Acquisition Corp
Average Annual Return | -5.42% |
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -14% |
Market Capitalization | 93m USD |
Shares Outstanding | 8 203 422 |
Percentage of Shares Shorted | 0.06% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
MedTech Acquisition Corp. is a blank check company, whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Greenwich, Connecticut. The company went IPO on 2020-12-18. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm intends to focus on businesses primarily operating in the healthcare sector in the United States. The firm has not commenced any business operations and has not generated any revenue.